[Drug resistance and floral distribution of Pseudomonas aeruginosa]

C Y Jia1

  • 1Plastic Surgery Center, Xijing Hospital, Fourth Military Medical University, Xi-an.

Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi = Zhonghua Zheng Xing Shao Shang Waikf [I.E. Waike] Zazhi = Chinese Journal of Plastic Surgery and Burns
|September 1, 1990
PubMed

Insights

Pseudomonas aeruginosa strains showed serious antibiotic resistance. Ceftazidime, norfloxacin, and amikacin were most effective, indicating a need for strengthened isolation measures in burn units.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Burn wound infections

Background:

  • Pseudomonas aeruginosa is a common opportunistic pathogen in burn wound infections.
  • Antibiotic resistance in P. aeruginosa poses a significant challenge in clinical settings.

Purpose of the Study:

  • To investigate the antibiotic susceptibility patterns of Pseudomonas aeruginosa strains isolated from a burn ward.
  • To identify prevalent serotypes and assess the extent of cross-infection.

Main Methods:

  • Isolation and identification of 100 P. aeruginosa strains from burn patients between June 1986 and September 1989.
  • Antibiotic susceptibility testing and minimum inhibitory concentration (MIC) determination.
  • Serotyping investigation to determine the predominant serotype.

Main Results:

  • High levels of resistance to commonly used antibiotics were observed.
  • Ceftazidime, norfloxacin, and amikacin demonstrated the lowest MIC values, indicating higher susceptibility.
  • Serotype P 11 was identified as the predominant strain, with evidence of cross-infection.

Conclusions:

  • The study highlights a serious antibiotic resistance problem with P. aeruginosa in the burn ward.
  • Ceftazidime, norfloxacin, and amikacin are potential therapeutic options.
  • Strengthened isolation protocols are crucial to control the spread of P. aeruginosa, particularly serotype P 11, and prevent cross-infection.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...